Mar. 3, 2025 — Psoriasis is one of the most common chronic inflammatory skin diseases, affecting around 250,000 people in Austria. While previous treatment approaches have mainly focused on ...

Explore the dos and don’ts for living with psoriasis. If you’re living with psoriasis, you probably already know how ...

More than half of patients with fingernail psoriasis achieved complete fingernail clearance after 68 weeks of guselkumab treatment.

A study finds that 99% of dietary advice for psoriasis on Instagram is low-quality, often unsubstantiated and posted by ...

Opens in a new tab or window Despite recent significant advances in systemic therapies for psoriasis, topical treatment retains a prominent role for many patients. The American Academy of ...

Opens in a new tab or window Until about 20 years ago, systemic treatment options for moderate/severe psoriasis were limited and nonspecific. To get an idea of how much the field has changed ...

Positive results were reported for Johnson & Johnson's psoriasis drug during.a late-breaking research session today at the ...

The latest research report published by Vantage Market Research, titled "An Increase in Demand and Opportunities for the ...

Adults and adolescents treated with icotrokinra experienced improvements in their moderate to severe plaque psoriasis, ...

A 27.6% increase occurred in the global incidence of pediatric psoriasis, with the largest increases among areas of lower sociodemographic indexes.

Two posters presented at the 2025 American Academy of Dermatology Annual Meeting highlighted the importance of improving ...

Data demonstrated favorable safety and local tolerability of ZORYVE® (roflumilast) cream 0.15% in adults and children with atopic dermatitis (AD) ...